Results 111 to 120 of about 20,430,225 (174)

Pattern of care and treatment outcomes of metastatic non-clear cell kidney cancer: a single centre experience from India. [PDF]

Ecancermedicalscience
Roy S, Raychaudhuri S, Biswas B, Dabkara D, Bhattacherjee A, Ganguly S, Ghosh J, Patel YS, Pal S, Karmakar J, Mitra A, Gupta S.   +11 more
europepmc   +1 more source

Qualitative and quantitative assessment of non-clear cell renal cell carcinoma using contrast-enhanced ultrasound. [PDF]

BMC Urol
Zhang W, Wang J, Chen L, Shi J.
europepmc   +1 more source

Correction: Qualitative and quantitative assessment of non-clear cell renal cell carcinoma using contrast-enhanced ultrasound. [PDF]

BMC Urol
Zhang W, Wang J, Chen L, Shi J.
europepmc   +1 more source

The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study. [PDF]

World J Urol
Dai J, He B, Zhang Y, Zhang H, Hu X, Xu L, Ni Y, Zhang X, Sun G, Zeng H, Shen P, Liu Z.   +11 more
europepmc   +1 more source

MRI-based radiomics machine learning model to differentiate non-clear cell renal cell carcinoma from benign renal tumors. [PDF]

Eur J Radiol Open
Wang R, Zhong L, Zhu P, Pan X, Chen L, Zhou J, Ding Y.   +6 more
europepmc   +1 more source

[Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Guo B, Lu M, Wang G, Zhang H, Liu L, Hou X, Zhao L, Tian X, Zhang S.   +8 more
europepmc   +1 more source

Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial. [PDF]

Eur Urol
Fitzgerald KN, Lee CH, Voss MH, Carlo MI, Knezevic A, Peralta L, Chen Y, Lefkowitz RA, Shah NJ, Owens CN, McHugh DJ, Aggen DH, Laccetti AL, Kotecha RR, Feldman DR, Motzer RJ.   +15 more
europepmc   +1 more source

Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Non-Clear Cell Renal Cell Carcinoma. [PDF]

Int J Mol Sci
Chrabańska M, Szweda-Gandor N, Rynkiewicz M, Hraboš D, Drozdzowska B.   +4 more
europepmc   +1 more source

Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial.

JAMA Netw Open
Gulati S, Tangen C, Ryan CW, Vaishampayan UN, Shuch BM, Barata PC, Pruthi DK, Bergerot CD, Tripathi A, Lerner SP, Thompson IM, Lara PN, Pal SK.   +12 more
europepmc   +1 more source

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan. [PDF]

Int J Clin Oncol
Yoshimura A, Kato T, Nakai Y, Tsujihata M, Toyoda S, Sato M, Matsuzaki K, Nakata W, Takao T, Inoguchi S, Okuda Y, Yamamichi G, Ishizuya Y, Yamamoto Y, Hatano K, Kawashima A, Takada S, Inoue H, Nishimura K, Miyake O, Fujita K, Nakayama M, Nishimura K, Nonomura N.   +23 more
europepmc   +1 more source